rs128621204
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000061.3(BTK):c.1684C>T(p.Arg562Trp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R562P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000061.3 missense
Scores
Clinical Significance
Conservation
Publications
- Bruton-type agammaglobulinemiaInheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Myriad Women’s Health, Orphanet, ClinGen
- isolated growth hormone deficiency type IIIInheritance: XL Classification: STRONG, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemiaInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BTK | NM_000061.3 | c.1684C>T | p.Arg562Trp | missense_variant | Exon 17 of 19 | ENST00000308731.8 | NP_000052.1 | |
| BTK | NM_001287344.2 | c.1786C>T | p.Arg596Trp | missense_variant | Exon 17 of 19 | NP_001274273.1 | ||
| BTK | NM_001287345.2 | c.1156C>T | p.Arg386Trp | missense_variant | Exon 15 of 17 | NP_001274274.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
X-linked agammaglobulinemia Pathogenic:2
Variant summary: BTK c.1684C>T (p.Arg562Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183615 control chromosomes. c.1684C>T has been observed in multiple individuals affected with X-Linked Agammaglobulinemia (example, Hagemann_1994, Vorechovsky_1995, Wattanasirichaigoon_2006, Chan_2006, Conley_1994, Danielian_2003, Lopez-Herrera_2007). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 15661032, 16160918, 7849697, 9545398, 12655572, 7880320, 9445504, 11742281, 11809909, 12405164, 7809124, 7711734, 16712653, 16951917, 17765309, 17967562). ClinVar contains an entry for this variant (Variation ID: 11383). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
Autosomal recessive agammaglobulinemia 1 Pathogenic:1
- -
X-linked agammaglobulinemia with growth hormone deficiency Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 562 of the BTK protein (p.Arg562Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with X-linked agammaglobulinemia (PMID: 7880320, 11742281, 16951917, 17765309, 19904586). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 11383). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt BTK protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at